619 related articles for article (PubMed ID: 20169517)
1. Recent improvements in the clinical treatment of coagulation factor inhibitors.
Franchini M; Lippi G
Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
3. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
Kershaw G; Jayakodi D; Dunkley S
Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
[TBL] [Abstract][Full Text] [Related]
4. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.
Franchini M; Mannucci PM
Br J Clin Pharmacol; 2011 Oct; 72(4):553-62. PubMed ID: 21204915
[TBL] [Abstract][Full Text] [Related]
6. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance therapy in patients with acquired hemophilia.
von Depka M
Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
[TBL] [Abstract][Full Text] [Related]
8. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
[TBL] [Abstract][Full Text] [Related]
10. Current management of acquired factor VIII inhibitors.
Barnett B; Kruse-Jarres R; Leissinger CA
Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors in congenital coagulation disorders.
Key NS
Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
[TBL] [Abstract][Full Text] [Related]
12. Urgent inhibitor issues: targets for expanded research.
Hoots WK
Haemophilia; 2006 Dec; 12 Suppl 6():107-13. PubMed ID: 17123403
[TBL] [Abstract][Full Text] [Related]
13. FEIBA versus NovoSeven in hemophilia patients with inhibitors.
Franchini M; Coppola A; Tagliaferri A; Lippi G
Semin Thromb Hemost; 2013 Oct; 39(7):772-8. PubMed ID: 24014071
[TBL] [Abstract][Full Text] [Related]
14. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.
Gouw SC; van den Berg HM
Semin Thromb Hemost; 2009 Nov; 35(8):723-34. PubMed ID: 20169509
[TBL] [Abstract][Full Text] [Related]
15. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
Astermark J
Haemophilia; 2006 Jul; 12 Suppl 3():52-60. PubMed ID: 16683997
[TBL] [Abstract][Full Text] [Related]
16. Overview of inhibitors.
Astermark J
Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
[TBL] [Abstract][Full Text] [Related]
17. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
18. Laboratory identification of factor inhibitors: an update.
Kershaw G; Favaloro EJ
Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
[TBL] [Abstract][Full Text] [Related]
19. Postpartum acquired factor VIII inhibitors.
Franchini M
Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
[TBL] [Abstract][Full Text] [Related]
20. Acquired hemophilia A: a concise review.
Franchini M; Gandini G; Di Paolantonio T; Mariani G
Am J Hematol; 2005 Sep; 80(1):55-63. PubMed ID: 16138334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]